VRVishal N. Rao
Vishal N. Rao
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Vishal N. Rao has a total of 303 co-authors. Here are the top co-authors by number of shared publications:
Marat Fudim
11 shared publications- Marat Fudim
Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC; Duke Clinical Research Institute, Durham, NC
9 shared publications Robert J. Mentz
7 shared publicationsRyan J. Tedford
5 shared publications- Adam D. DeVore
Duke Clinical Research Institute, Durham, NC, USA
4 shared publications G. Michael Felker
4 shared publications
Latest Publications
- Open Access
- 7 November 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (12)
Exercise-Induced Tricuspid Regurgitation
- 7 November 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (12)
Open AccessExercise-Induced Tricuspid Regurgitation
- Open Access
- 3 October 2026
- Published by Elsevier in Journal of Cardiac Failure - Intersections
Fluid Challenge in the Hemodynamic Gray Zone: Is It Time to Lower the Bar?
- 3 October 2026
- Published by Elsevier in Journal of Cardiac Failure - Intersections
Open AccessFluid Challenge in the Hemodynamic Gray Zone: Is It Time to Lower the Bar?
- 29 September 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (13) , 1277-1285
Under Pressure: When Heart Failure Isn’t Full
- 29 September 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (13) , 1277-1285
Under Pressure: When Heart Failure Isn’t Full
- 1 June 2026
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 19 (6) , 684-687
The Dual Menaces of Atrial Fibrillation and Tricuspid Regurgitation in Heart Failure
- 1 June 2026
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 19 (6) , 684-687
The Dual Menaces of Atrial Fibrillation and Tricuspid Regurgitation in Heart Failure
- 4 May 2026
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 32 (10) , 1727-1729
Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction: One Step Closer to Therapeutic Targets?
- 4 May 2026
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 32 (10) , 1727-1729
Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction: One Step Closer to Therapeutic Targets?
- Open Access
- 1 April 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (13) , 107266
Temporary Left Ventricular Assist Device for Peripartum Cardiogenic Shock as a Bridge to Cesarean Delivery
- 1 April 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (13) , 107266
Open AccessTemporary Left Ventricular Assist Device for Peripartum Cardiogenic Shock as a Bridge to Cesarean Delivery
- Open Access
- 27 February 2026
- Published by Elsevier in Journal of Cardiac Failure - Intersections
Implications of Exercise Wedge Pressure in Heart Failure With Preserved Ejection Fraction Identified by Pressure-Flow Slopes
- 27 February 2026
- Published by Elsevier in Journal of Cardiac Failure - Intersections
Open AccessImplications of Exercise Wedge Pressure in Heart Failure With Preserved Ejection Fraction Identified by Pressure-Flow Slopes
- 20 November 2025
- Published by Elsevier in JACC: Heart Failure
- Vol. 14 (3)
Heart Failure With Preserved Ejection Fraction Across the Spectrum of Body Mass Index
- 20 November 2025
- Published by Elsevier in JACC: Heart Failure
- Vol. 14 (3)
Heart Failure With Preserved Ejection Fraction Across the Spectrum of Body Mass Index
- 13 November 2025
- Published by Elsevier in JACC: Heart Failure
- Vol. 14 (3)
In-Hospital Virtual Consultation to Implement Guideline-Directed Medical Therapy for Cardiovascular-Kidney-Metabolic Disease
- 13 November 2025
- Published by Elsevier in JACC: Heart Failure
- Vol. 14 (3)
In-Hospital Virtual Consultation to Implement Guideline-Directed Medical Therapy for Cardiovascular-Kidney-Metabolic Disease